161 related articles for article (PubMed ID: 36709109)
41. Splenic lymphoma with circulating villous lymphocytes.
Imbing F; Kumar D; Kumar S; Yuoh G; Gardner F
J Clin Pathol; 1995 Jun; 48(6):584-7. PubMed ID: 7665709
[TBL] [Abstract][Full Text] [Related]
42. Primary splenic presentation of malignant lymphoma and related disorders. A study of 49 cases.
Kraemer BB; Osborne BM; Butler JJ
Cancer; 1984 Oct; 54(8):1606-19. PubMed ID: 6548171
[TBL] [Abstract][Full Text] [Related]
43. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.
Baseggio L; Traverse-Glehen A; Petinataud F; Callet-Bauchu E; Berger F; Ffrench M; Couris CM; Thieblemont C; Morel D; Coiffier B; Salles G; Felman P
Haematologica; 2010 Apr; 95(4):604-12. PubMed ID: 20015887
[TBL] [Abstract][Full Text] [Related]
44. Leukemic meningitis in a patient with splenic lymphoma with villous lymphocytes (SLVL). Meningitis as a possible initial manifestation of SLVL.
Yamazaki K; Shimizu S; Negami T; Sawada K; Nanasawa H; Ohta M; Konda S; Okuda K
Cancer; 1994 Jul; 74(1):61-5. PubMed ID: 8004584
[TBL] [Abstract][Full Text] [Related]
45. Splenic B-cell lymphoma with villous lymphocytes (SLVL). A lymphocytic lymphoma simulating hairy cell leukemia. A study of 8 cases.
Valensi F; Durand V; Bastenaire B; Flandrin G
Nouv Rev Fr Hematol (1978); 1990; 32(6):409-14. PubMed ID: 2101874
[TBL] [Abstract][Full Text] [Related]
46. An Aggressive Course of Transformed Splenic Diffuse Red Pulp Small B-Cell Lymphoma With Novel Somatic Loss-of-Function Mutation in
Christensen LM; Severinsen MT; Katoch P; Ovlisen AK; Hoyer T; Jensen P; Dybkaer K; Kristensen DT
J Hematol; 2023 Jun; 12(3):118-122. PubMed ID: 37435411
[TBL] [Abstract][Full Text] [Related]
47. The histopathology of prolymphocytic leukaemia with particular reference to the spleen: a comparison with chronic lymphocytic leukaemia.
Lampert I; Catovsky D; Marsh GW; Child JA; Galton DA
Histopathology; 1980 Jan; 4(1):3-19. PubMed ID: 7353816
[TBL] [Abstract][Full Text] [Related]
48. Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients.
Parry-Jones N; Matutes E; Gruszka-Westwood AM; Swansbury GJ; Wotherspoon AC; Catovsky D
Br J Haematol; 2003 Mar; 120(5):759-64. PubMed ID: 12614206
[TBL] [Abstract][Full Text] [Related]
49. Toll-like receptor expression and function differ between splenic marginal zone B cell lymphoma and splenic diffuse red pulp B cell lymphoma.
Verney A; Traverse-Glehen A; Callet-Bauchu E; Jallades L; Magaud JP; Salles G; Genestier L; Baseggio L
Oncotarget; 2018 May; 9(34):23589-23598. PubMed ID: 29805758
[TBL] [Abstract][Full Text] [Related]
50. CD5-Negative, CD10-Negative Low-Grade B-Cell Lymphoproliferative Disorders of the Spleen.
Schmieg JJ; Muir JM; Aguilera NS; Auerbach A
Curr Oncol; 2021 Dec; 28(6):5124-5147. PubMed ID: 34940069
[TBL] [Abstract][Full Text] [Related]
51. Development of B-cell prolymphocytic leukemia in a patient with splenic diffuse red pulp small B-cell lymphoma.
Cheng WY; Zhu YM; Cheng S; Chen YS; Shen Y
Leuk Lymphoma; 2018 Aug; 59(8):1990-1993. PubMed ID: 29199492
[No Abstract] [Full Text] [Related]
52. [Splenic marginal zone lymphoma].
Mohamed S
Pan Afr Med J; 2017; 26():111. PubMed ID: 28533834
[TBL] [Abstract][Full Text] [Related]
53. [Experience in investigating splenic red pulp lymphoma].
Al-Radi LS; Moiseeva TN; Julhakyan HL; Ntanishyan KI; Kovrigina AM; Glebova SM; Lugovskaya SA; Dvirnyk VN; Khvastunova AN; Yakutik IA; Savchenko VG
Ter Arkh; 2016; 88(4):53-60. PubMed ID: 27070164
[TBL] [Abstract][Full Text] [Related]
54. [Splenic lymphoma with circulating villous lymphocytes].
Colović M; Janković G; Colović R; Mijović A; Antunović P
Srp Arh Celok Lek; 1994; 122(3-4):103-4. PubMed ID: 17972822
[TBL] [Abstract][Full Text] [Related]
55. Splenic marginal zone lymphoma.
Dogan A; Isaacson PG
Semin Diagn Pathol; 2003 May; 20(2):121-7. PubMed ID: 12945935
[TBL] [Abstract][Full Text] [Related]
56. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
57. The role of splenectomy in management of splenic B-cell lymphomas.
Archibald WJ; Baran AM; Williams AM; Salloum RM; Richard Burack W; Evans AG; Syposs CR; Zent CS
Leuk Res; 2023 May; 128():107053. PubMed ID: 36906942
[TBL] [Abstract][Full Text] [Related]
58. Splenic marginal zone cell lymphoma: report of an indolent variant without massive splenomegaly presumably representing an early phase of the disease.
Rosso R; Neiman RS; Paulli M; Boveri E; Kindl S; Magrini U; Barosi G
Hum Pathol; 1995 Jan; 26(1):39-46. PubMed ID: 7821915
[TBL] [Abstract][Full Text] [Related]
59. Micronodular T-cell/histiocyte-rich large B-cell lymphoma of the spleen: histology, immunophenotype, and differential diagnosis.
Dogan A; Burke JS; Goteri G; Stitson RN; Wotherspoon AC; Isaacson PG
Am J Surg Pathol; 2003 Jul; 27(7):903-11. PubMed ID: 12826882
[TBL] [Abstract][Full Text] [Related]
60. Nodal and splenic marginal zone B cell lymphomas.
Mollejo M; Camacho FI; Algara P; Ruiz-Ballesteros E; García JF; Piris MA
Hematol Oncol; 2005; 23(3-4):108-18. PubMed ID: 16307458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
